Our team

“Ron Peleg wins plaudits as “Israel’s leading pharmaceutical products lawyer”. His exceptional practice “continues to amaze year after year”.
Who’s who legal Product Liability Defence 2021

“Ron Peleg is known as ‘Mr. Pharmaceutical Products Liability in Israel’, with impressed commentators opining that he ‘has become the absolute go-to lawyer in Israel’ for such work”
Who’s who legal Life Sciences 2021

“The ‘top-notch’ Ron Peleg is a guru in the pharmaceutical and automotive product liability areas, offering clients authoritative representation in high level class actions and other disputes”
Who’s who legal Product liability Defence 2019

“Ron Peleg is ‘The top name in Israel’ according to one peer. He provides clients with ‘very timely advice’ on a range of issues in the [pharmaceutical] field and is said to ‘know his way around the courts well'”
Who’s who legal Life Sciences 2019

Ron Peleg is an “excellent, smart and sophisticated litigator” who is praised for his work in pharmaceuticals. Sources state that “there is no comparison” and that he has “really tremendous experience in successfully defending multinationals” with “great legal skills and a confident, smart approach”.
Who’s who Product liability Defence 2018

“Works on highly complex matters involving foreign clients. Other commentators describe him as ‘a brilliant young lawyer with great analytical skills and plenty of energy’.”
Chambers and Partners

“Responsive and practical” lawyer, who has “great legal skills” and is praised for his advice to international clients”
Chambers and Partners

“The “excellent” Ron Peleg is one of Israel’s foremost life sciences specialists, winning praise from sources for his “efficient and highly professional approach”
Who’s Who Legal

Ron Peleg is a partner in the firm’s Litigation Group. Ron’s practice focuses on product liability, class actions, Pharmaceutical, Automotive, Regulatory Administrative and Commercial law His clients include leading multinationals and local, companies and manufacturers. Ron commonly handles high profile, complex, cross border litigation.

Ron is the former Associate Editor of the “Tel Aviv University Law Review”.

Ron has been selected as a leading practitioner by “Who’s Who Legal” in Product Liability (since 2010) and Life Sciences (since 2014).

• Defense of Merck in a class action concerning the vaccine Gardasil.
• Defense of Merck Sharp & Dohme (Israel) in a class action concerning the drug Propecia.
• Defense of Merck & Co. in all pending actions in Israel concerning the pain relief medication Vioxx, including three class actions filed in this matter.
• Defense of GlaxoSmithKline in a class action concerning the drug Avandia.
• Defense of GlaxoSmithKline in a class action concerning the drug Eltroxin.
• Defense of Eli Lilly & Co in a class action concerning the drug Zyprexa.
• Defense of AstraZeneca in a class action concerning the drug Crestor.
• Defense of Bayer in a class action concerning the contraceptives Yasmin&Yaz.
• Defense of Monsanto and Bayer in a class action concerning agrochemical product “RoundUp”.
• Defense of Volkswagen and Audi in class actions regarding the emissions of diesel engines.
• Defense of Volkswagen Group and Champion Motors in consumer class actions.
• Defense of Renault Group in consumer class actions
• Defense of ISUZU in a class action regarding behavior of diesel engines.
• Defense of Expedia Inc. in a class action concerning consumer refund.
• Defense of a leading multinational electronics company in class actions concerning mobile and TV devices.
• Defense of Clal Biotechnology Industries Ltd. (CBI) and D-Pharm in a class action related to an experimental drug and related securities issues.
• Representation of the innovative stent manufacturer Medinol in its multibillion-dollar dispute with Boston Scientific.

• Co-author (with Noam Gilon) of the article ” ‘Breach of Autonomy’- A Unique Israeli Damages Theory” (For The Defense, September 2018). For the full article, click here.
• Panelist in WWL: Product Liability Defence 2018 roundtable. For the full article, click here.
• Co-author (with Noam Gilon) of the article “The Rise of Class Action in Israel” (In-House Defense Quarterly, Fall 2017). For the full article, click here.
• Co-author (with Dr. Israel Leshem and Edan Laron) of the Israeli chapter in: “The Chambers Legal Practice Guide: Litigation 2014-15”.
• Co-author (with Dr. Israel Leshem) of the Israeli chapter in: “The International Comparative Legal Guide to: Class and Group Actions 2010, A practical insight to cross-border Class and Group Actions work”. Published by Global Legal Group, London. http://www.iclg.co.uk. For the full article, click here.
• Co-author (with Dr. Israel Leshem) of the Israeli chapter in: “The International Comparative Legal Guide to: International Arbitration 2009”, A practical insight to cross-border international arbitration work. Published by Global Legal Group, London. http://www.iclg.co.uk/. For the full article, click here.
• Co-author (with Gilad Schiff) of the Israeli chapter in: “The International Comparative Legal Guide to Pharmaceutical Advertising 2009- A practical insight to cross-border Pharmaceutical Advertising work”. Published by Global Legal Group, London. http://www.iclg.co.uk/. For the full article, click here.
• Co-author (with Dr. Israel Leshem) of The Israeli Chapter in: “The International Comparative Legal Guide to: Litigation and Dispute Resolution 2009”, A practical insight to cross-border litigation and dispute resolution. Published by Global Legal Group, London. http://www.iclg.co.uk. For the full article, click here.